Probiotics and Irritable Bowel Syndrome (IBS): Evidence Update and Practical Considerations for Primary Care

Dr Dave Chatoor is a Neurogastro Surgeon at University College London Hospitals NHS Foundation Trust in London, U.K. In this webinar, Dr Dave Chatoor delivers a summary of the current management guidelines for irritable bowel syndrome (IBS), including an overview of the potential of specific probiotic strains including Bifidobacterium longum 35624™ and Bifidobacterium longum 1714™. Dr Chatoor discusses the latest research, alongside reflections of his own clinical experience with individuals with IBS, including practical tips for communicating with individuals regarding their symptoms and management approaches.